336 results on '"Girón, Rosa"'
Search Results
2. Bronquiectasias no debidas a fibrosis quística
3. Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: A follow-up study
4. Psychometric Validation of the Patient-Reported Experience Measure (PREM) Questionnaire “HowRwe” in Patients With Respiratory Disease Receiving Home Respiratory Therapies
5. The U-Shaped Relationship Between Eosinophil Count and Bronchiectasis Severity: The Effect of Inhaled Corticosteroids
6. Effects of a remotely supervised resistance training program on muscle strength and body composition in adults with cystic fibrosis: Randomized controlled trial
7. Filamentous fungi in the airway of patients with cystic fibrosis: Just spectators?
8. C-Reactive Protein Concentration in Steady-State Bronchiectasis: Prognostic Value of Future Severe Exacerbations. Data From the Spanish Registry of Bronchiectasis (RIBRON)
9. RIBRON: The Spanish online bronchiectasis registry. Characterization of the first 1912 patients
10. RIBRON: el registro español informatizado de bronquiectasias. Caracterización de los primeros 1.912 pacientes
11. Las bronquiectasias como enfermedad compleja
12. Bronchiectasis: A Complex, Heterogeneous Disease
13. Las bronquiectasias: una enfermedad compleja y heterogénea
14. Predictive value of computed tomography scoring systems evolution in adults with cystic fibrosis
15. Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells
16. Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity
17. The Binding of Pseudomonas aeruginosa to Cystic Fibrosis Bronchial Epithelial Model Cells Alters the Composition of the Exosomes They Produce Compared to Healthy Control Cells.
18. Bronchiectasis: Changes in the Characterization of Patients During 20 Years of Follow-up. Data from the Spanish Bronchiectasis Registries
19. Continuous Glucose Monitoring as an Additional Tool in Early Cystic Fibrosis-Related Diabetes Monitoring and in Evaluation of Short-Term Sitagliptin Response
20. Efficacy and Safety of Dry Powder Antibiotics: A Narrative Review
21. Spanish Guidelines on the Evaluation and Diagnosis of Bronchiectasis in Adults
22. Spanish Guidelines on Treatment of Bronchiectasis in Adults
23. Normativa sobre el tratamiento de las bronquiectasias en el adulto
24. Normativa sobre la valoración y el diagnóstico de las bronquiectasias en el adulto
25. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study
26. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study
27. Etiology of Bronchiectasis in a Cohort of 2047 Patients. An Analysis of the Spanish Historical Bronchiectasis Registry
28. Etiología de las bronquiectasias en una cohorte de 2.047 pacientes. Análisis del registro histórico español
29. Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio
30. Bronchopulmonary infection–colonization patterns in Spanish cystic fibrosis patients: Results from a national multicenter study
31. ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study.
32. Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients
33. Consenso español para la prevención y el tratamiento de la infección bronquial por Pseudomonas aeruginosa en el paciente con fibrosis quística
34. Peripheral Neutrophil-to-Lymphocyte Ratio in Bronchiectasis: A Marker of Disease Severity
35. Chryseobacterium spp., ¿nuevo patógeno oportunista asociado a fibrosis quística?
36. Impact of Chronic Bronchial Infection by Staphylococcus aureus on Bronchiectasis
37. Association Between Evolution of Mucus Plugging, Parenchymal Alterations and Air Trapping on Computed Tomography and Risk of Exacerbations in Adults With Cystic Fibrosis
38. Influence on sputum microbiology with CFTR modulator (tezacaftor-ivacaftor) in adult patients with cystic fibrosis: Multicenter study
39. Validation of a Quality of Life Questionnaire for Bronchiectasis: psychometric analyses of the Spanish QOL-B-V3.0
40. Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid
41. Changes in structural lung disease in cystic fibrosis children over 4 years as evaluated by high-resolution computed tomography
42. Blood Neutrophil Counts Define Specific Clusters of Bronchiectasis Patients: A Hint to Differential Clinical Phenotypes
43. New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
44. Temporal Changes on Pulmonary Artery Size on Computed Tomography in Adults With Cystic Fibrosis
45. Systemic Inflammatory Biomarkers Define Specific Clusters in Patients with Bronchiectasis: A Large-Cohort Study
46. Clinical course of patients with bronchiolitis obliterans following hematopoietic stem cell transplantation
47. Usefulness of the CONUT index upon hospital admission as a potential prognostic indicator of COVID-19 health outcomes
48. Nebulized saline treatment in patients with concomitant asthma and bronchiectasis
49. Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
50. Differences in Nutritional Status and Inflammatory Biomarkers between Female and Male Patients with Bronchiectasis: A Large-Cohort Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.